Exosomes: what families are actually asking us
Exosomes are microscopic vesicles released by cells and are being studied for their role in cell communication. Clinical uses remain an evolving area of research, and evidence, regulation and safety vary by product, route and indication. This page exists because parents ask, and because they deserve a straight answer rather than a sales page.
If you have arrived here after reading a clinic advertisement, a social media post or a testimonial, the most useful thing you can do next is bring it to a consultation and have it read critically with you.
Three very different things get called “treatment”
Almost every difficult conversation about exosomes comes from these three being blurred together. They are not the same, and the difference decides what protection you have.
Standard care
An intervention with an established evidence base for a defined indication, approved by regulators, and delivered as routine medical practice with known risks and known benefit.
A registered clinical trial
Investigational use inside a formally approved study, with ethics committee oversight, a written protocol, monitoring, adverse-event reporting and no charge to the family for the investigational product.
Investigational use
Offered outside both of the above. Laboratory findings and early studies cannot be treated as proof of benefit for autism, ADHD, developmental delay or other conditions, and the oversight that comes with a trial is not automatically present.
What is reasonably established, and what is not
Both columns matter. Families are usually shown only the first one.
Reasonably established
- Exosomes are real biological particles released by cells
- They can carry proteins, lipids and nucleic acids between cells
- That role in cell communication is a legitimate and active area of scientific research
- Research interest spans many medical fields, and studies are ongoing
Not established
- That a commercial preparation is safe or effective for a particular patient — research findings do not automatically transfer to a product on a shelf
- That any of it treats autism, ADHD or developmental delay
- That two products are comparable: source, manufacturing, purity, storage, dose and route can materially change risk and quality
- That an absence of reported short-term problems tells you anything about long-term safety in a growing child
Questions to ask any provider — including us
These are the questions a provider should be able to answer without hesitation and in writing. If any of them produce discomfort, that itself is information.
- Is this use standard care, part of a registered clinical trial, or investigational?
- What exactly is the product, who manufactures it, and where?
- What is the regulatory status of this product and of this facility in Egypt?
- What testing has this specific batch undergone, and can I see it?
- What are the known short-term risks, and what is honestly unknown about the long term?
- What published evidence exists for this indication, in this age group?
- How would an adverse event be recognised, managed and reported?
- What are the established alternatives, and what happens if we decline?
- What is the total cost, and what does it cover if the course is stopped?
- Will you put the answers to all of the above in writing?
Before considering an investigational intervention for a child, seek an independent specialist opinion from someone who is not providing the intervention. That is not a criticism of any clinic — it is simply how a decision this size should be made.
What a consultation here actually covers
It is a medical discussion, not an intake step toward a product.
Clinical history
Diagnosis, current treatment, previous tests and investigations, medicines and supplements, and what matters most to your family right now.
Evidence review
What is known, what remains uncertain, and whether the published evidence actually applies to the indication and age you are asking about — including reading anything you have been sent.
Safer next steps
Established care options, appropriate referrals, and a follow-up plan based on your child’s individual needs rather than on a product.
Please note: a consultation does not confirm eligibility and does not mean an intervention will be recommended or provided. Any medical service is subject to clinician judgement, informed consent, product verification and current regulatory requirements. If the honest answer is “not for your child, and here is what to do instead”, that is the answer you will get.
A consultant, with a name
Conversations like this are held by qualified paediatricians, not by a sales or reception team.
Dr. Mohamed AfifyConsultant Pediatrician & Functional Neurologist — sets the medical direction for the functional medicine track
Dr. Ehab El EmamConsultant Paediatrician & Neonatologist — medical consultations and follow-up
Dr. Ahmed RamzyConsultant Developmental-Behavioural Paediatrician — where the question is about autism, ADHD or development
Questions families ask us
Do you give exosomes to children with autism?
We do not present exosomes as a treatment for autism. Autism is supported here through assessment and structured developmental, behavioural and therapy programmes with measurable follow-up. If you are asking about exosomes specifically, the consultation is a discussion about evidence and safety, and it may well end with us advising against.
Someone told me it worked for their child. What do I do with that?
Take it seriously as something that family experienced, and hold it lightly as evidence. Children change for many reasons at once — development, a therapy programme, a school change, time. That is exactly why individual stories cannot establish that an intervention works, and why we will not use them to persuade you either.
Is it legal in Egypt?
Regulatory status depends on the specific product, its route of administration and the facility, and it can change. Ask any provider to state the current status of the exact product they are proposing, and to show you the documentation rather than describe it.
What are the risks?
Risks depend entirely on the product and how it is given, and honest disclosure includes what is not yet known. Any injected biological preparation carries infection, immune-reaction and contamination risks, and product quality varies with source, manufacturing, purity and storage. Long-term effects in growing children are not established.
Why does this page not sell anything?
Because on this subject the useful thing we can offer a family is an evidence-aware conversation, not a product page. Our clinical rule is simple: nothing at this clinic is offered with a promised outcome, and an investigational intervention is not marketed to parents of children with a developmental diagnosis.
What should we do instead?
Start with the whole-child medical review and, where relevant, a structured developmental assessment. Most families who arrive asking about exosomes have not yet had either done thoroughly, and it is common for that work to change the picture considerably.
Can we bring the material we were sent?
Please do — brochures, protocols, messages, videos, price lists, anything. Reading it with a clinician is one of the most useful hours you can spend before making a decision.
Does a consultation commit us to anything?
No. The care team confirms the consultation fee when you book, and it commits you to nothing: it is a medical opinion, and declining any suggestion afterwards changes nothing about the rest of your child’s care with us.
Established care we do provide
Functional medicine
The whole-child medical review that should come before any decision like this.
Specialised assessment
Structured developmental and behavioural evaluation with a written plan.
Integrated programme
Coordinated therapy across departments with measurable follow-up.
All services
Every department and programme at Spectra Egypt in one place.
Medically reviewed by the Spectra Cure Clinic Egypt clinical team — Dr. Mohamed Afify and Dr. Ehab El Emam. Last reviewed July 2026. This page provides general medical information and is not a diagnosis, a treatment recommendation or a promise of availability. Regulatory status and evidence can change; confirm current information with the treating clinician and the relevant authorities. Spectra Cure Clinic Egypt, 2nd Floor, Building B, Saga Boulevard Complex, Mohamed Naguib Axis, New Cairo 3.
Start with an evidence-aware medical discussion
Bring what you have read and what you have been told. A consultant will go through it with you and set out the established options — including saying no.
Medical information on this page is general and is not a diagnosis or a personal treatment recommendation. In an emergency, call 123 or go to the nearest emergency department immediately.
